Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58


The predictive factors of recurrent deep vein thrombosis.

Farzamnia H, Rabiei K, Sadeghi M, Roghani F.

ARYA Atheroscler. 2011 Fall;7(3):123-8.


The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease.

Stain M, Schönauer V, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Kyrle PA, Eichinger S.

J Thromb Haemost. 2005 Dec;3(12):2671-6.


Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors.

Hansson PO, Sörbo J, Eriksson H.

Arch Intern Med. 2000 Mar 27;160(6):769-74.


Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago.

Ziegler S, Schillinger M, Maca TH, Minar E.

Thromb Res. 2001 Jan 15;101(2):23-33.


The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.

Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, Bernardi E, Girolami B, Simioni P, Girolami A.

Haematologica. 1997 Jul-Aug;82(4):423-8.


Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.

Delis KT, Hunt N, Strachan RK, Nicolaides AN.

Thromb Haemost. 2001 Sep;86(3):817-21.


Symptomatic perioperative venous thromboembolism is a frequent complication in patients with a history of deep vein thrombosis.

Liem TK, Huynh TM, Moseley SE, Minjarez RC, Landry GJ, Mitchell EL, Deloughery TG, Moneta GL.

J Vasc Surg. 2010 Sep;52(3):651-7. doi: 10.1016/j.jvs.2010.04.029.


Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: an increasing population at risk.

Sandoval JA, Sheehan MP, Stonerock CE, Shafique S, Rescorla FJ, Dalsing MC.

J Vasc Surg. 2008 Apr;47(4):837-43. doi: 10.1016/j.jvs.2007.11.054.


Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients.

Galanaud JP, Quenet S, Rivron-Guillot K, Quere I, Sanchez Muñoz-Torrero JF, Tolosa C, Monreal M; RIETE INVESTIGATORS..

J Thromb Haemost. 2009 Dec;7(12):2028-34. doi: 10.1111/j.1538-7836.2009.03629.x.


Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.

Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I, Nony P, Sanson C, Boissel JP; Investigators of the "Durée Optimale du Traitement AntiVitamines K" (DOTAVK) Study..

Circulation. 2001 May 22;103(20):2453-60.


Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.

Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM.

Circulation. 2004 Aug 3;110(5):566-70.


Evolution of deep venous thrombosis: a 2-year follow-up using duplex ultrasound scan and strain-gauge plethysmography.

Haenen JH, Wollersheim H, Janssen MC, Van 't Hof MA, Steijlen PM, van Langen H, Skotnicki SH, Thien T.

J Vasc Surg. 2001 Oct;34(4):649-55.


The measurement and monitoring of surgical adverse events.

Bruce J, Russell EM, Mollison J, Krukowski ZH.

Health Technol Assess. 2001;5(22):1-194. Review.


One decade "narcotic addicted patients with deep vein thrombosis" in st. Alzahra hospital of isfahan, iran.

Abdar Esfahani M, Sayehmiri F.

Addict Health. 2014 Summer-Autumn;6(3-4):127-37.


Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.

Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.

Haematologica. 2000 Dec;85(12):1271-6.


[Preliminary study on epidemiology of deep venous thrombosis of lower extremity in patients with high risk].

Zhang W, Shi ZY, Fu WG, Wang YQ.

Zhonghua Yi Xue Za Zhi. 2009 Dec 8;89(45):3176-80. Chinese.

Items per page

Supplemental Content

Support Center